These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16951234)

  • 41. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer.
    De Young MP; Damania H; Scheurle D; Zylberberg C; Narayanan R
    In Vivo; 2002; 16(4):239-48. PubMed ID: 12224133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
    Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
    Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
    Fedarko NS; Jain A; Karadag A; Van Eman MR; Fisher LW
    Clin Cancer Res; 2001 Dec; 7(12):4060-6. PubMed ID: 11751502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S; Szmitkowski M; Wojtukiewicz M
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
    Ciardiello F; Tortora G; Bianco C; Selvam MP; Basolo F; Fontanini G; Pacifico F; Normanno N; Brandt R; Persico MG
    Oncogene; 1994 Jan; 9(1):291-8. PubMed ID: 8302592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.
    Salomon DS; Bianco C; De Santis M
    Bioessays; 1999 Jan; 21(1):61-70. PubMed ID: 10070255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
    Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
    J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-G is a potential tumor marker in malignant ascites.
    Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
    Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland.
    Kenney NJ; Huang RP; Johnson GR; Wu JX; Okamura D; Matheny W; Kordon E; Gullick WJ; Plowman G; Smith GH
    Mol Reprod Dev; 1995 Jul; 41(3):277-86. PubMed ID: 8588926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
    Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
    Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration.
    Watanabe K; Bianco C; Strizzi L; Hamada S; Mancino M; Bailly V; Mo W; Wen D; Miatkowski K; Gonzales M; Sanicola M; Seno M; Salomon DS
    J Biol Chem; 2007 Oct; 282(43):31643-55. PubMed ID: 17720976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.
    Brandt R; Normanno N; Gullick WJ; Lin JH; Harkins R; Schneider D; Jones BW; Ciardiello F; Persico MG; Armenante F
    J Biol Chem; 1994 Jun; 269(25):17320-8. PubMed ID: 8006041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.
    Ruggiero D; Nappo S; Nutile T; Sorice R; Talotta F; Giorgio E; Bellenguez C; Leutenegger AL; Liguori GL; Ciullo M
    PLoS Genet; 2015 Jan; 11(1):e1004976. PubMed ID: 25629528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer.
    Miyoshi N; Ishii H; Mimori K; Sekimoto M; Doki Y; Mori M
    Int J Oncol; 2010 Mar; 36(3):563-8. PubMed ID: 20126975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients.
    Wu Y; Han B; Sheng H; Lin M; Moore PA; Zhang J; Wu J
    Int J Cancer; 2003 Jul; 105(5):724-32. PubMed ID: 12740925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.